Pattern of bleeding and response to therapy in Glanzmann thrombasthenia

Haemophilia

Volumn 18, Issue 6, 2012, Pages

  Borhany, M ^a   Fatima, H ^b   Naz, A ^a   Patel, H ^a   Shamsi, T ^a  

^a Haemostasis and Thrombosis ^*  (Pakistan)

^b National Institute of Blood Disease and Bone Marrow Transplantation (NIBD)   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; DESMOPRESSIN; ORAL CONTRACEPTIVE AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ADOLESCENT; ADULT; BLEEDING; CHILD; CLINICAL ARTICLE; ECCHYMOSIS; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; GINGIVA BLEEDING; GLANZMANN DISEASE; HEMATURIA; HUMAN; INFANT; LETTER; MALE; MENORRHAGIA; MUSCLE BLEEDING; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; THROMBOCYTE AGGREGATION; THROMBOCYTE TRANSFUSION; TREATMENT RESPONSE;

ANTIFIBRINOLYTIC AGENTS; CONTRACEPTIVES, ORAL; FACTOR VIIA; FEMALE; HEMORRHAGE; HUMANS; MALE; PLATELET TRANSFUSION; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; THROMBASTHENIA; TRANEXAMIC ACID;

EID: 84868212241     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12017     Document Type: Letter

References (10)

1. Newman PJ, Seligsohn U, Lyman S, Coller BS. The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc Natl Acad Sci USA 1991; 88: 3160-4.
2. Toogeh G, Sharifian R, Lak M, Safaee R, Artoni A, Peyvandi F. Presentation and pattern of symptoms in 382 patients with Glanzmann thrombasthenia in Iran. Am J Hematol 2004; 77: 198-9.
3. Christine MG, Fangping C, Changhong W, Harvey JW, Barry SC, Deborah LF. Glycoprotein IIb Leu214Pro Mutation Produces Glanzmann Thrombasthenia with both Quantitative and Qualitative Abnormalities in GPIIb/IIIa. Blood 1998; 91: 1562-71.
4. Nurden AT. Glanzmann thrombasthenia. Orphanet J Rare Dis 2006; 1: 10.
5. Borhany M, Pahore Z, Qadr UZ et al. Bleeding disorders in the tribe: result of consanguineous in breeding. Orph J Rare Dis 2010; 5: 23. http://www.ojrd.com/content/5/1/23.
6. Alamelu J, Liesner R. Modern management of severe platelet function disorders. Br J Haematol 2010; 149: 813-23. Epub 2010 Apr 29.
7. Kujovich JL. von Willebrand's disease and menorrhagia: prevalence, diagnosis, and management. Am J Hematol 2005; 79: 220-8.
8. Karimi M, Ravanbod S, Cohan N, Ala F. How to deal with medical and social aspects of bleeding disorders-preparing women and the family in developing countries. Haemophilia 2011; 17(Suppl 1): 42-4. doi:10.1111/j.1365-2516.2011.02565.
9. Rosas RR, Kurth MH, Sidman J. Treatment and outcomes for epistaxis in children with Glanzmann's Thrombasthenia. Laryngoscope 2010; 120: 2374-7.
10. Poon MC. Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia. Vasc Health Risk Manag 2007; 3: 655-64.